Showing results (1541-1550 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|March 2, 2017
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic AdenocarcinomaAl B Benson, Zev A Wainberg, J Randolph Hecht, et al.The Oncologist|March 19, 2017
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular FunctionFilipa Lynce, Ana Barac, Ming T Tan, et al.The Oncologist|February 4, 2021
FOLFOXIRI plus Bevacizumab Versus FOLFOX plus Panitumumab for Metastatic Left-Sided RAS/BRAF Wild-Type Colorectal Cancer: Which "Side" Are You On?Irene S Yu, Jonathan M LoreeThe Oncologist|October 6, 2019
Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Practical Implications for the Community OncologistCaron A Jacobson, Umar Farooq, Armin GhobadiThe Oncologist|August 15, 2019
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre ExperienceHamzeh Albaba, Tristan A Barnes, Zachary Veitch, et al.The Oncologist|August 15, 2019
An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and ImmunotherapiesJingyu Cao, Lijuan Chen, Heng Li, et al.The Oncologist|September 8, 2019
Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is UnclearJeffrey Peppercorn, Eric Campbell, Steve Isakoff, et al.The Oncologist|September 11, 2019
Cost and Utilization of Lung Cancer End-of-Life Care Among Racial-Ethnic Minority Groups in the United StatesYufan Chen, Steven D Criss, Tina R Watson, et al.The Oncologist|August 27, 2020
Cancer and Risk of COVID-19 Through a General Community SurveyKarla A Lee, Wenjie Ma, Daniel R Sikavi, et al.Pageof 571